Original-host source document
Interactive PDF served from the official AAR archive
Public project summary
Melanoma affects over 100,000 Americans every year. We can combine more granular insights from single cell biology with clinical information from bulk RNA sequencing data. Using drug-labelled single cell data alongside melanoma clinical data from The Cancer Genome Atlas (TCGA) we extract promising general and drug response specific gene markers and examine their relationship with patient survival. We found gene signatures related to cell type, treated with drugs, and survival that will help design treatments to kill cancer cells rather than normal cells. We also generated a pipeline to do this analysis.
- Public attribution
- Jenny S.
- Issue
- Volume 5 · 2019-20
- Research area
- STEAM
- Source program
- Advanced Authentic Research · PAUSD
